542 related articles for article (PubMed ID: 21220752)
1. Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production.
Toyonaga J; Tsuruya K; Ikeda H; Noguchi H; Yotsueda H; Fujisaki K; Hirakawa M; Taniguchi M; Masutani K; Iida M
Nephrol Dial Transplant; 2011 Aug; 26(8):2475-84. PubMed ID: 21220752
[TBL] [Abstract][Full Text] [Related]
2. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1.
Shibata S; Nagase M; Yoshida S; Kawachi H; Fujita T
Hypertension; 2007 Feb; 49(2):355-64. PubMed ID: 17200434
[TBL] [Abstract][Full Text] [Related]
3. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
4. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
5. Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat.
Pessôa BS; Peixoto EB; Papadimitriou A; Lopes de Faria JM; Lopes de Faria JB
J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):56-66. PubMed ID: 21987533
[TBL] [Abstract][Full Text] [Related]
6. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
8. Spironolactone ameliorates podocytic adhesive capacity via restoring integrin alpha 3 expression in streptozotocin-induced diabetic rats.
Lin S; Li D; Jia J; Zheng Z; Jia Z; Shang W
J Renin Angiotensin Aldosterone Syst; 2010 Sep; 11(3):149-57. PubMed ID: 20525748
[TBL] [Abstract][Full Text] [Related]
9. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
10. Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions.
Lee SH; Yoo TH; Nam BY; Kim DK; Li JJ; Jung DS; Kwak SJ; Ryu DR; Han SH; Lee JE; Moon SJ; Han DS; Kang SW
Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1381-90. PubMed ID: 19710242
[TBL] [Abstract][Full Text] [Related]
11. Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren2 rat.
Whaley-Connell A; Habibi J; Wei Y; Gutweiler A; Jellison J; Wiedmeyer CE; Ferrario CM; Sowers JR
Am J Physiol Renal Physiol; 2009 May; 296(5):F1013-22. PubMed ID: 19261739
[TBL] [Abstract][Full Text] [Related]
12. Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors.
Nagase M; Yoshida S; Shibata S; Nagase T; Gotoda T; Ando K; Fujita T
J Am Soc Nephrol; 2006 Dec; 17(12):3438-46. PubMed ID: 17082236
[TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
[TBL] [Abstract][Full Text] [Related]
14. Extract of Rhizoma Polygonum cuspidatum reduces early renal podocyte injury in streptozotocin‑induced diabetic rats and its active compound emodin inhibits methylglyoxal‑mediated glycation of proteins.
Sohn E; Kim J; Kim CS; Jo K; Kim JS
Mol Med Rep; 2015 Oct; 12(4):5837-45. PubMed ID: 26299942
[TBL] [Abstract][Full Text] [Related]
15. Renal podocyte apoptosis in Zucker diabetic fatty rats: involvement of methylglyoxal-induced oxidative DNA damage.
Kim J; Sohn E; Kim CS; Kim JS
J Comp Pathol; 2011 Jan; 144(1):41-7. PubMed ID: 20541219
[TBL] [Abstract][Full Text] [Related]
16. Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner.
Sonneveld R; van der Vlag J; Baltissen MP; Verkaart SA; Wetzels JF; Berden JH; Hoenderop JG; Nijenhuis T
Am J Pathol; 2014 Jun; 184(6):1715-26. PubMed ID: 24731445
[TBL] [Abstract][Full Text] [Related]
17. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
[TBL] [Abstract][Full Text] [Related]
18. Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species.
van den Hoven MJ; Waanders F; Rops AL; Kramer AB; van Goor H; Berden JH; Navis G; van der Vlag J
Nephrol Dial Transplant; 2009 Sep; 24(9):2637-45. PubMed ID: 19429930
[TBL] [Abstract][Full Text] [Related]
19. Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide.
Yuan P; Xue H; Zhou L; Qu L; Li C; Wang Z; Ni J; Yu C; Yao T; Huang Y; Wang R; Lu L
Nephrol Dial Transplant; 2011 Jul; 26(7):2119-26. PubMed ID: 21208996
[TBL] [Abstract][Full Text] [Related]
20. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
Shibata S; Nagase M; Fujita T
J Am Soc Nephrol; 2006 Mar; 17(3):754-64. PubMed ID: 16452496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
